This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Ratio-Metformin
- Starting date:
- July 4, 2013
- Posting date:
- July 17, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-34663
Recalled products
- Ratio-Metformin
Reason
Low levels of identified foreign material on ratio Metformin 500mg tablets were observed during an internal Quality investigation. The foreign material has been identified as discoloured granulation, coating material, aluminum, ferrous oxide, fibrous material and polyethylene terephthalate (PET).
Depth of distribution
Wholesalers, Retailers, Pharmacies.
Affected products
A. Ratio-Metformin
DIN, NPN, DIN-HIM
DIN 02242974
Dosage form
Tablet
Strength
- 500 mg
Lot or serial number
- 35205136B
- 35205138A
- 35205363B
- 35205215B
- 35205270B
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA